|
Volumn 26, Issue 1 SUPPL. 2, 1999, Pages 117-122
|
Review and outlook for the role of paclitaxel in urothelial carcinoma
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CARBOPLATIN;
CISPLATIN;
DOXORUBICIN;
METHOTREXATE;
PACLITAXEL;
VINBLASTINE;
ANTINEOPLASTIC ACTIVITY;
CANCER ADJUVANT THERAPY;
CANCER COMBINATION CHEMOTHERAPY;
CLINICAL TRIAL;
CONFERENCE PAPER;
DRUG TOLERABILITY;
HUMAN;
KIDNEY FAILURE;
MULTIMODALITY CANCER THERAPY;
NEPHROTOXICITY;
PATIENT SELECTION;
PRIORITY JOURNAL;
UROGENITAL TRACT CANCER;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CLINICAL TRIALS;
HUMANS;
NEOPLASM METASTASIS;
PACLITAXEL;
URINARY BLADDER NEOPLASMS;
|
EID: 0033034904
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (13)
|
References (5)
|